10.11.2015 12:29:42
|
Dr. Reddy's Statement On Temporary Restraining Order For Esomeprazole Capsules
(RTTNews) - Dr. Reddy's Laboratories (RDY) in a statement issued today said that it has been made aware of an order passed by the District Court of Delaware, USA, granting a Temporary Restraining Order (TRO) with immediate effect on sales, delivery, transfer, or other disposition of its generic esomeprazole product in the US market.
Dr. Reddy's said it is complying with the order of the Court and simultaneously evaluating all possible options to resolve the matter at the earliest.
The order came about as a result of a motion moved by Astra Zeneca objecting to the usage of the colour Purple in the said generic product.
The order has been passed pending further hearing or trial. The Court has asked the parties to propose a next course of action and submit the same to the court. The court shall conduct a telephonic status conference on Thursday, November 12, 2015.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AstraZeneca PLC (spons. ADRs)mehr Nachrichten
06.03.25 |
Angespannte Stimmung in New York: NASDAQ 100 gibt am Nachmittag nach (finanzen.at) | |
06.03.25 |
Anleger in New York halten sich zurück: NASDAQ 100 sackt mittags ab (finanzen.at) | |
06.03.25 |
Schwache Performance in New York: NASDAQ 100 beginnt Handel in der Verlustzone (finanzen.at) | |
05.03.25 |
Mittwochshandel in New York: NASDAQ 100 beendet die Mittwochssitzung in der Gewinnzone (finanzen.at) | |
05.03.25 |
Optimismus in New York: NASDAQ 100 nachmittags freundlich (finanzen.at) | |
05.03.25 |
Mittwochshandel in New York: NASDAQ 100 zeigt sich mittags leichter (finanzen.at) | |
05.03.25 |
Verluste in New York: NASDAQ 100 zum Handelsstart leichter (finanzen.at) | |
04.03.25 |
NASDAQ 100-Handel aktuell: NASDAQ 100 beendet die Sitzung weit in der Verlustzone (finanzen.at) |
Analysen zu AstraZeneca PLC (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
AstraZeneca PLC (spons. ADRs) | 71,50 | -0,69% |
|
Dr. Reddy's Laboratories Ltd. (Spons. ADRS) | 12,00 | 0,00% |
|